(3)

Telehealth best practices: How to best care for your patients when ...

05/20/21 - Authority Magazine

AccessHope’s CMO Dr. Todd Sachs recently spoke with Authority Magazine about his background in healthcare and lessons he has learned throughout his career. In the interview, he articulates the benefits of in-person visits while discussing the challenges of virtual visits for patients, and then based on his experience, shares ways physicians can make the most of remote healthcare, especially for those living with cancer.

Robert Stone: City of Hope aims to transform cancer care nationally ...

04/02/21 - The Cancer Letter

AccessHope offers a new model that remotely connects more people with cancer through their employer health benefits to world-class cancer support from the leading institutions City of Hope and Northwestern Medicine. By engaging these employees’ local healthcare providers into collaborative relationships, AccessHope is extending the reach of leading cancer expertise to elevate local cancer care, creating a system that increases patient access to potentially lifesaving support.

Democratizing Cutting Edge Oncology Health Care by Broadening Access ...

03/05/21 - Pharmacy Times

City of Hope’s Dr. Harlan Levine spoke at the Association of Community Cancer Centers’ 47th Annual Meeting & Cancer Business Summit to share how AccessHope’s unique business model helps to unlock access to leading-edge cancer expertise and bridge the cancer knowledge gap.

Why Not Adore ADAURA?—The Trial We Need vs the Trial We Got

02/04/21 - JAMA Oncology

AccessHope’s Executive Medical Director, Jack West, MD, shares his perspective on lung cancer treatment advancements and the recent results of the ADAURA trial in a Viewpoint for JAMA Oncology.

Supporting Your Employees Facing Cancer

02/03/21 - WorldatWork

AccessHope CEO Mark Stadler shares how employer demand is accelerating the need for innovative cancer support services, driven by the goals to spend healthcare dollars wisely and ensure the best possible outcomes and quality of life for employees navigating a cancer journey.

Ruxolitinib for the Treatment of Steroid-Refractory Chronic ...

01/27/21 - JAMA Network Open

AccessHope’s Vice President and Executive Clinical Director Joseph Alvarnas, MD, published a study in JAMA Network Open highlighting the use of a new treatment for the potentially life-ending chronic graft-vs-host disease (cGVHD) resulting from allogeneic hematopoietic stem cell transplantation (HSCT).

Interview with Mark Stadler, CEO, AccessHope

12/24/20 - Employee Benefits & Wellness Excellence

AccessHope CEO Mark Stadler shares with HR.com’s Employee Benefits & Wellness Excellence. Mark highlights how AccessHope is supporting its employees during unprecedented times with programs that promote workplace wellness.

Reimagining Cancer Care Delivery—and Serving Employers—Through ...

12/18/20 - AJMC

AccessHope Board Chair Dr. Harlan Levine spoke with AJMC’s Evidence-Based Oncology™ on the evolution of employers’ interest in cancer care, and the role they are playing to connect employees with leading-edge research.

Breakthrough Cancer Therapies Offer Hope for Patients

12/09/20 - U.S. News

City of Hope’s Dr. Michael Caligiuri discussed how AccessHope works with employers to provide access to NCI center expertise and assists local oncologists to help develop treatment plans for employees.

AccessHope Partners With Northwestern to Expand Cancer Expertise ...

11/30/20 - Healthcare Innovation

AccessHope recently announced a novel collaboration with Northwestern Medicine to extend remote delivery of world-renowned cancer expertise and help more people achieve the best possible outcomes. CEO Mark Stadler shares the details.

Contact us to get started

Hope begins here.